Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SWEET DEGRADATION

Financiado

Cerrado

GOLGITACs Targeted Degradation of Golgi Apparatus residing Carbohydrate Process...

GOLGITACs Targeted Degradation of Golgi Apparatus residing Carbohydrate Processing Enzymes Oligosaccharides and glycoconjugates, a hugely diverse class of biomolecules, are closely associated with health and many diseases. Carbohydrate metabolism relies mainly on glycosidases and glycosyltransferases which are carbohydr... ver más

31/12/2029

Líder desconocido

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto Líder desconocido

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-10-16

ERC-2024-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 1 año

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITEIT LEIDEN

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 62 meses Fecha Inicio: 2024-10-16
Fecha Fin: 2029-12-31

Líder del proyecto Líder desconocido

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Oligosaccharides and glycoconjugates, a hugely diverse class of biomolecules, are closely associated with health and many diseases. Carbohydrate metabolism relies mainly on glycosidases and glycosyltransferases which are carbohydrate processing enzymes (CPEs) that break and create glycosidic bonds, respectively. Controlling their activities is vital for understanding pathological processes in, and developing therapeutics for glycan-related diseases. Recently, new targeted protein degradation (TPD) technologies, which disable disease-related proteins by degradation, have opened possibilities for proteins that are otherwise hard to inhibit. While TPD within the cytoplasm, cell membrane, and extracellular space can be achieved with current approaches, proteins in the Golgi apparatus can not be degraded by means of the current methods, yet it is a major cellular compartment where most CPEs reside. New TPD strategies targeting Golgi apparatus-resident proteins would be a major solution for CPE-related diseases with unmet medical needs. SWEET DEGRADATION aims to develop strategies that allow for the first time the degradation of proteins located in the Golgi apparatus, opening ways for a new therapeutic modality. The driving idea behind this proposal is that a molecule can be designed thatselect CPEs in the Golgi for targeted protein degradation. Such molecules, which I term GolgiTACs, will link a CPE to a Golgi transporter, either sortilin or cation-independent mannose-6-phosphate receptor (CI-M6PR), and shuttle CPEs to the lysosome for degradation. In aim 1, I will focus on developing the GolgiTAC technology whereas in aim 2, GolgiTACs will be exploited for targeted protein degradation of CPEs in disease models. In all, SWEET DEGRADATION will deliver a conceptually new general strategy to target Golgi proteins for degradation, thus providing new inroads to develop therapeutics for currently untreatable diseases.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores